Successful Treatment of an Infected Zenith Fenestrated Endograft Without Explantation

Vasc Endovascular Surg. 2018 Oct;52(7):569-572. doi: 10.1177/1538574418774663. Epub 2018 May 7.

Abstract

Current surgical dogma for infected aortic endografts consists of complete explantation concurrent with revascularization via extra-anatomic bypass or in situ infection-resistant conduit. However, this treatment paradigm is associated with high rates of postoperative mortality and major morbidity. Therefore, patients with prohibitive operative risk are often not offered surgical intervention. In the following manuscript, we report the successful treatment of an 85-year-old gentleman with a fenestrated aortic endograft (Cook Medical, Bloomington, Indiana) infected secondary to the formation of an aortoenteric fistula with primary bowel repair, washout, and lifelong antibiotics and followed for nearly 2 years after intervention. Therefore, this nonexplantation approach can be considered for patients who may otherwise have no surgical recourse.

Keywords: AAA; FEVAR; explantation; graft; infection; nonoperative.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage*
  • Aortic Aneurysm, Abdominal / diagnostic imaging
  • Aortic Aneurysm, Abdominal / surgery*
  • Aortography / methods
  • Blood Vessel Prosthesis / adverse effects*
  • Blood Vessel Prosthesis Implantation / adverse effects*
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Computed Tomography Angiography
  • Endovascular Procedures / adverse effects*
  • Endovascular Procedures / instrumentation*
  • Humans
  • Male
  • Prosthesis Design
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology
  • Stents / adverse effects*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents